|
Market Closed -
Nasdaq
21:00:00 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
+0.13% | +182.32% |
| 08-27 | Argenx SE completed the acquisition of Forte Biosciences, Inc.. | CI |
| 08-27 | Argenx Completes Acquisition of Forte Biosciences | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORTE BIOSCIENCES, INC. | Bio Therapeutic Drugs | +0.03% | +0.13% | +182.32% | +589.87% | -89.08% | 1.94B |  | | |
- Stock Market
- Stocks
- FBRX Stock
- Charts Forte Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
